Daito Pharmaceutical Co Market capitalization 2024

The Daito Pharmaceutical Co Market capitalization history

YEAR	REVENUE (undefined JPY)	GROSS MARGIN (%)	NET INCOME (undefined JPY)
2027e	55.97	18,46	6.37
2026e	56.36	18,33	4.45
2025e	52.52	19,67	3.89
2024e	47.37	21,81	3.04
2023	45.1	22,91	3.6
2022	43.46	26,36	4.67
2021	48.71	22,17	4.25
2020	44.99	21,07	3.94
2019	41.13	21,08	3.51
2018	39.88	20,34	3.04
2017	37.98	20,41	2.66
2016	36.37	19,98	2.57
2015	34.06	20,75	2.25
2014	31.2	19,18	1.81
2013	28.96	20,46	1.79
2012	27.15	20,85	1.39
2011	25.23	18,66	0.99
2010	22.68	16,29	0.75
2009	21.52	16,66	0.69
2008	20.76	18,19	0.75
2007	16.99	17,17	0.71
2006	15.54	17,04	0.47
2005	14.17	17,17	-0.63

Daito Pharmaceutical Co Aktienanalyse

What does Daito Pharmaceutical Co do?

Daito Pharmaceutical Co Ltd is a Japanese pharmaceutical company that was founded in 1947. The company is headquartered in Osaka and is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. Daito Pharmaceutical specializes in the development and manufacturing of medications and has a strong presence in the East Asia region. History: Daito Pharmaceutical was founded by Masaharu Imai, a pharmacist driven by the idea of producing medications that would help people and alleviate suffering. The company started as a small family business, producing a limited number of medications in a workshop in Osaka. Some of the earliest products were injection solutions and ready-to-use medications. In the 1950s, Daito Pharmaceutical expanded its product range and began developing medications for chronic diseases such as diabetes and heart diseases. The company also expanded geographically and started selling its products in other parts of Japan. In the following years, Daito Pharmaceutical expanded its capabilities and presence through mergers and acquisitions. One of the most significant acquisitions was the acquisition of Union Chemical Industry Co Ltd in 1973. This acquisition expanded Daito Pharmaceutical's portfolio with new products and technologies, as well as customers and distribution channels in other countries. Business model: Daito Pharmaceutical is a company that focuses on the development, manufacturing, and marketing of prescription and OTC medications. The company is divided into several business units that specialize in specific therapeutic areas. One of Daito Pharmaceutical's largest business units is the oncology division. Here, the company works on developing new cancer medications and supports doctors in the treatment of patients with cancer. Another business unit is the neurology division, which focuses on the development of medications for the treatment of neurological disorders such as Alzheimer's and Parkinson's. Products: Daito Pharmaceutical offers a wide range of medications that can be used for a variety of conditions. The company's products are divided into various therapy areas, including cardiology, oncology, neurology, and gastroenterology. An example of a Daito Pharmaceutical product is Nazastat (Nafazaon), a medication used for the treatment of type 2 diabetes. It is administered orally and works by inhibiting glucose production in the liver and improving insulin sensitivity in muscle and fat tissues. Another product of Daito Pharmaceutical is Tegosept (Methisazin), a medication used for the treatment of upper respiratory tract infections such as sinusitis and pharyngitis. The medication is administered orally and works by inhibiting the growth of bacteria such as Streptococcus and Staphylococcus. Conclusion: Daito Pharmaceutical Co Ltd is a Japanese pharmaceutical company that specializes in the development, manufacturing, and marketing of medications. The company has a long history in the industry and has expanded its capabilities and presence over the years through mergers and acquisitions. Daito Pharmaceutical has several business units specializing in different therapeutic areas, including oncology, neurology, and cardiology. The company offers a wide range of medications that can be used for a variety of conditions. Daito Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Daito Pharmaceutical Co's Market Capitalization

Daito Pharmaceutical Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Daito Pharmaceutical Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Daito Pharmaceutical Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Daito Pharmaceutical Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Daito Pharmaceutical Co Stock

What is the current Daito Pharmaceutical Co market capitalization?

The current market capitalization of Daito Pharmaceutical Co is 35.58 B JPY.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Daito Pharmaceutical Co.

How has the market capitalization of Daito Pharmaceutical Co developed in recent years?

The market capitalization of Daito Pharmaceutical Co has increased/decreased by 7.09% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Daito Pharmaceutical Co?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Daito Pharmaceutical Co?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Daito Pharmaceutical Co have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Daito Pharmaceutical Co pay?

Over the past 12 months, Daito Pharmaceutical Co paid a dividend of 60 JPY . This corresponds to a dividend yield of about 2.67 %. For the coming 12 months, Daito Pharmaceutical Co is expected to pay a dividend of 65.13 JPY.

What is the dividend yield of Daito Pharmaceutical Co?

The current dividend yield of Daito Pharmaceutical Co is 2.67 %.

When does Daito Pharmaceutical Co pay dividends?

Daito Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Daito Pharmaceutical Co?

Daito Pharmaceutical Co paid dividends every year for the past 18 years.

What is the dividend of Daito Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 65.13 JPY are expected. This corresponds to a dividend yield of 2.9 %.

In which sector is Daito Pharmaceutical Co located?

Daito Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Daito Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Daito Pharmaceutical Co from 8/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Daito Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Daito Pharmaceutical Co in the year 2023?

In the year 2023, Daito Pharmaceutical Co distributed 39.091 JPY as dividends.

In which currency does Daito Pharmaceutical Co pay out the dividend?

The dividends of Daito Pharmaceutical Co are distributed in JPY.